Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.

× No keyword cloud information.

7 in total

1. Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012.

Authors: Michael Bröker; Suzana Bukovski; Davor Culic; Susanne Jacobsson; Maria Koliou; Markku Kuusi; Maria João Simões; Anna Skoczynska; Maija Toropainen; Muhamed-Keir Taha; Georgina Tzanakaki
Journal: Hum Vaccin Immunother Date: 2014-03-07 Impact factor: 3.452

2. Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.

Authors: David Pace; Ameneh Khatami; Jennifer McKenna; Danielle Campbell; Simon Attard-Montalto; Jacqueline Birks; Merryn Voysey; Catherine White; Adam Finn; Emma Macloed; Saul N Faust; Alison Louise Kent; Paul T Heath; Ray Borrow; Matthew D Snape; Andrew J Pollard
Journal: BMJ Date: 2015-04-01

3. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.

Authors: Dorothea M C Hill; Jay Lucidarme; Stephen J Gray; Lynne S Newbold; Roisin Ure; Carina Brehony; Odile B Harrison; James E Bray; Keith A Jolley; Holly B Bratcher; Julian Parkhill; Christoph M Tang; Ray Borrow; Martin C J Maiden
Journal: Lancet Infect Dis Date: 2015-10-27 Impact factor: 25.071

4. Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs.

Authors: Myint Tin Tin Htar; Sally Jackson; Paul Balmer; Lidia Cristina Serra; Andrew Vyse; Mary Slack; Margarita Riera-Montes; David L Swerdlow; Jamie Findlow
Journal: BMC Public Health Date: 2020-12-09 Impact factor: 3.295

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.

1. Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012.

2. Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.

3. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.

4. Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs.

5. Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.

Review 6. Sex differences in pediatric infectious diseases.

7. Meningococcal carriage in children and young adults in the Philippines: a single group, cross-sectional study.